MD&A · 2025
In this section4 topics
Overview of Operations
Overview of Operations
For the full year 2025, the Company’s total revenue amounted to Baht 3,107.48 million, an increase of 8.86% from the previous year. The key driver remained the hospital operations revenue, which totaled Baht 3,061.82 million, reflecting a growth rate of 8.95% compared to the prior year.
The Non-Capitation segment generated total annual revenue of Baht 2,398.72 million, an increase of 6.85% compared to the previous year, demonstrating the success of the Company’s ongoing efforts to expand its patient base.
The Company generated total revenue from the Social Security Scheme of Baht 708.59 million, an increase of 14.40% compared to the previous year. This continuous growth throughout the year reflects the stability of the Recurring Income base, as well as the increasing trust and confidence among insured persons who choose to register and utilize the hospital’s services.
Other Income for the year ended December 31, 2025, other income amounted to THB 45.66 million, representing a growth of 2.78%. The Company recognized a non-operating special item of THB 2.77 million from a provision for litigation damages.
Operating Results & Financial Condition
Operating Results & Profitability
Profitability
For the full year 2025, profitability continued to expand consistently. The Company recorded a total net profit of Baht 437.44 million, an increase of 38.65% YoY. EBITDA grew by 26.85%, leading the annual net profit margin to rise to 14.08%, compared to 11.05% in the preceding year. These figures underscore the Company’s strong financial position and enhanced profitability potential.
Revenues and profits of the Company and its subsidiaries for the years 2023 - 2025 (each hospital)
Name of Hospital | 2025 | 2024 | 2023 | |||
Thousand baht | % | Thousand baht | % | Thousand baht | % | |
Vichaivej International Hospital Omnoi | ||||||
: Revenue from sales and services | 1,194,914.96 | 38 | 1,079,522.37 | 35 | 1,066,809.31 | 39 |
: Net profit | 546,256.42 | 68 | 560,245.52 | 71 | 156,940.35 | 45 |
Vichaivej International Hospital Nongkhaem | ||||||
: Revenue from sales and services | 949,701.46 | 31 | 907,067.10 | 32 | 899,190.10 | 32 |
: Net profit | 142,688.03 | 18 | 124,711.42 | 37 | 129,893.79 | 37 |
Vichaivej International Hospital Samuttsakhon | ||||||
: Revenue from sales and services | 740,172.31 | 24 | 672,273.38 | 23 | 626,460.70 | 23 |
: Net profit | 100,196.07 | 13 | 96,094.79 | 15 | 53,757.19 | 15 |
Vichaivej Hospital Yeakfaichai | ||||||
: Revenue from sales and services | 222,519.82 | 7 | 205,561.38 | 6 | 176,661.79 | 6 |
: Net profit | 8,750.11 | 1 | 12,159.03 | 2 | 7,104.51 | 2 |
Srivichai Vocational School | ||||||
: Net profit | (85.75) | 0 | 429.96 | 0 | 435.54 | 0 |
Watthanavejvivat Company Limited | ||||||
: Net profit | 3,034.99 | 0 | 70.86 | 0 | 0 | |
Total revenue before elimination transaction | 3,107,308.55 | 100 | 2,864,424.23 | 100 | 2,769,121.90 | 100 |
Value of transaction | 45,486.39 | - | 54,212.75 | - | 35,232.88 | - |
Total revenue after elimination transaction | 3,061,822.16 | - | 2,810,211.48 | - | 2,733,889.02 | - |
Total profit before elimination transaction | 800,839.88 | 100 | 793,711.58 | 100 | 348,131.38 | 100 |
Value of transaction | 363,400.64 | - | 478,198.46 | - | 63,291.76 | - |
Total profit after elimination transaction | 437,439.24 | - | 315,513.12 | - | 284,839.62 | - |
Growth Drivers
For the full year 2025, the Company’s total revenue amounted to Baht 3,107.48 million, an increase of 8.86% from the previous year. The key driver remained the hospital operations revenue, which totaled Baht 3,061.82 million, reflecting a growth rate of 8.95% compared to the prior year.
Hospital Operations Costs The Company successfully demonstrated efficient cost management by maintaining the increase in costs at a lower rate than revenue growth, both on a quarterly and annual basis. This resulted in a significant improvement in gross profitability.
For the Full Year 2025 (Ended December 31, 2025): The Company recorded total hospital operations costs of Baht 2,220.73 million, representing an increase of 5.05% from the previous year. In contrast, hospital operations revenue achieved a higher growth rate of 8.95%.
The increase in aforementioned costs is consistent with the growth in patient volume and total revenue. This was primarily driven by Variable Costs, such as doctor fees, as well as medical supplies and pharmaceutical expenses. Nevertheless, the Company’s ability to maintain a cost growth rate lower than that of its revenue reflects highly efficient resource management and the realization of Economies of Scale. This performance directly contributed to the expansion of the Company’s gross profit margin for both the fourth quarter and the full year 2025.
Total Selling and Administrative Expenses The Company successfully managed its SG&A expenses, achieving a reduction despite the growth in total revenue. This reflects operational efficiency and the realization of Economies of Scale.
For the Full Year 2025 (Ended December 31, 2025): Total SG&A expenses were Baht 339.04 million, a slight decrease of 0.56% from the previous year, even as total revenue grew by nearly 9%. Consequently, the SG&A-to-sales ratio for 2025 improved to 10.91%, compared to 11.94% in the same period last year.
The result of stringent control over both cost of sales and administrative expenses was a primary driver in significantly boosting the Company’s Net Profit Margin over the past year.
Total Finance Costs The Company and its subsidiaries successfully managed financial costs with high efficiency, resulting in a continuous reduction in financing burdens throughout every accounting period.
For the full year 2025, the Company’s total financial costs amounted to Baht 4.45 million, representing a decrease of 20.92% or Baht 1.18 million compared to the previous year. This reduction reflects the Company’s strong financial discipline and effective debt structure management, which are key factors in further strengthening the Company’s financial position and enhancing its overall profitability.
Liquidity & Capital Adequacy
As of December 31, 2025, the Company and its subsidiaries maintained a solid financial position with a high level of liquidity. Although the Statement of Cash Flows reported a net decrease in cash and cash equivalents of Baht 234.62 million, bringing the ending balance to Baht 807.29 million, this change primarily resulted from the strategic reallocation of excess liquidity into higher-yield investments. The details of cash flow movements from core activities are as follows
Cash Flow from Operating Activities: The Company generated a net cash inflow from operations of Baht 513.70 million. This underscores the Quality of Earnings and the efficiency of the core business in consistently generating strong cash flow.
Cash Flow from Investing Activities: There was a net cash outflow from investing activities of Baht 657.55 million. This was mainly attributed to the allocation of cash into Other Current Financial Assets (fixed deposits at financial institutions) to maximize returns on idle cash. Additionally, investments were made in building renovations and the procurement of medical equipment to support future business expansion.
Cash Flow from Financing Activities: Net cash used in financing activities amounted to Baht 90.76 million, primarily due to dividend payments to shareholders and the repayment of lease liabilities. However, this was partially offset by cash inflows from the exercise of stock options, which further strengthened the capital base.
While the ending balance of "Cash and Cash Equivalents" stood at Baht 807.29 million, when combined with fixed deposits reported under Other Current Financial Assets of Baht 570.13 million, the Company’s total cash and liquid assets reached a high of Baht 1,377.42 million.
These figures demonstrate the Company’s financial readiness and discipline in maintaining a liquidity cushion to withstand economic volatility, while remaining well-positioned for strategic investments to create long-term shareholder value.
Asset Management Capability
As of December 31, 2025, the Company and its subsidiaries maintained a robust and highly stable financial position. Significant changes in assets, liabilities, and shareholders' equity are as follows
Assets
Total assets amounted to Baht 4,477 million, representing an increase of 8.75% from the end of 2024. This growth reflects the expansion of the Company’s business base and its overall stability. Key assets include
Property, Plant, and Equipment (PPE): Representing 51% of total assets, valued at Baht 2,299 million, supporting high-quality medical service delivery.
Cash and Financial Assets: Accounting for 31% of total assets, or Baht 1,377 million. This significant year-on-year increase demonstrates a high level of financial liquidity.
Trade and other current receivables: increased by THB 107.41 million, mainly due to current trade receivables not yet due.
(Unit : Million baht) | |||
Consolidated financial statements | |||
2025 | 2024 | 2023 | |
Trade receivables - unrelated parties | |||
Aged on the basis of due dates | |||
Not yet due | 312.50 | 212.62 | 201.19 |
Past due | |||
Up to 3 months | 88.06 | 65.16 | 53.28 |
3 - 6 months | 21.26 | 11.65 | 24.05 |
6 - 12 months | 8.23 | 7.90 | 4.95 |
Over 12 months | 1.93 | 5.38 | 6.53 |
Total | 431.98 | 302.71 | 290.00 |
Less: Allowance for expected credit losses | (1.84) | (4.11) | (7.31) |
Total trade receivables - unrelated parties, net | 430.14 | 298.59 | 282.69 |
Total trade receivables - net | 430.14 | 298.59 | 282.69 |
Other current receivables - related parties | |||
Other current receivables | 0.36 | 1.34 | - |
Other current receivables - unrelated parties | 0.36 | 1.34 | - |
Other current receivables - unrelated parties | |||
Other current receivables | 4.58 | 5.42 | 4.68 |
Accrued income | |||
Accrued social security income | 140.54 | 160.90 | 126.98 |
Accrued national health security income | - | 0.83 | 0.83 |
Other accrued income | 64.48 | 63.19 | 64.85 |
Total | 209.60 | 230.35 | 197.35 |
Less: Allowance for expected credit losses | (4.96) | (2.56) | (2.322) |
Total other current receivables - unrelated parties, net | 204.65 | 227.79 | 195.03 |
Total other current receivables - net | 205.01 | 229.13 | 195.03 |
Total trade and other current receivables - net | 635.14 | 527.73 | 477.72 |
Outstanding social security income consists of:
The Social Security scheme includes revenue from capitated medical services, revenue from medical services provided outside the capitation arrangement, and revenue from medical services categorized under Diagnosis-Related Groups (DRGs) for high-cost cases (where the Adjusted Relative Weight [Adj RW] is greater than or equal to a specified threshold).
Revenue from the social security dental care project for insured persons.
Social Security Scheme revenue for insured persons in cases of influenza
Revenue from the health check-up program for insured persons
This represents a decrease of 20.36 million baht compared to 2024, due to the receipt of payments from the health promotion program for insured persons in workplaces.
The Company and its subsidiaries have a policy to establish an allowance for expected credit losses by analyzing the aging of each uncollectible debtor and having pursued collection to the fullest extent. A report on expected uncollectible debtors is prepared and submitted to the Director for approval of the allowance for doubtful accounts, categorized by debtor age as follows:
Debtors with an aging period of over 1 year from the due date.
Individual assessment of debtors with overdue balances where there is certainty regarding the collection of medical fees.
Liabilities
Total liabilities stood at Baht 597 million, remaining relatively stable compared to the previous year (a marginal increase of 0.08%). This slight increase was primarily due to accrued corporate income tax, consistent with the growth in net profit. Notably, the total liabilities-to-assets ratio remained very low at only 13% of the total capital structure.
Shareholders’ Equity
Total shareholders’ equity amounted to Baht 3,880 million, an increase of 10.22% from the prior year. The primary drivers were the continuous accumulation of net profit from operations and proceeds from the exercise of stock options (advance payment for shares). This reflects both operational efficiency and shareholder confidence in the Company.
The Statement of Financial Position as of December 31, 2025, underscores the Company’s solid financial structure, with shareholders' equity representing 87% of total assets. This strong cash position and high liquidity serve as a vital foundation for future business expansion and sustainable long-term growth.
Debt Securities with Financial Ratio Requirements
Debt Securities with Financial Ratio Requirements Issued?
No
Factors That May Affect Financial Condition
Factors or Incidents That May Materially Affect Financial Condition
1. Government policies and changes in capitation rates under government health schemes will affect the Group's revenue as follows:
• The Social Security scheme includes a lump-sum payment for medical services and additional payments for high-cost illnesses, as well as medical service rates based on risk and utilization rates. The payment model for medical services is a per capita lump-sum payment based on the number of insured persons, at a rate of 1,808 baht for general treatment (adjusted from 1,640 baht to 1,808 baht effective May 2023), 453 baht for risk-based treatment, and includes payments for medical services based on Diagnosis Related Groups (DRGs) with an Adjusted Relative Weight (Adj Rw) greater than or equal to 2
• The Social Security project for insured persons to receive dental care, including tooth extraction, filling, scaling, and wisdom tooth extraction, costs 900 baht per person per year. Services can be obtained at clinics, private hospitals, or government hospitals at the convenience of the insured, without having to pay upfront.
• The Social Security Program for Insured Persons, specifically regarding the influenza vaccine, allows insured persons aged 50 and above to receive a free influenza vaccine at designated medical facilities once a year. This program ran from May 1st to August 31st of each year and was extended to December 31st.
• Benefits for health promotion and disease prevention are jointly provided by the Social Security Office and the National Health Security Office. This allows Thai insured persons to access health promotion and disease prevention services at hospitals in the social security system that are registered as service units in the national health security system. In addition to the annual health check-ups that the Social Security Office has set out above, Thai insured persons can also access health promotion and disease prevention services according to the categories specified by the NHSO.
2. The Vichaiyut Hospital Group is currently studying the feasibility of conducting business abroad to expand its foreign customer base in various countries through a network of agents and business partners abroad. The Group has also begun preparations to provide services to foreign customers, such as selecting employees with language skills for further training. The expansion of the foreign customer base may lead to changes in the revenue structure, which will affect the Group's profitability in the future.
3. The change in revenue structure focuses more on revenue from general customers, including business expansion from within and joint ventures with partners to expand hospital branches. The Vichaiyut Hospital Group has a business expansion plan that focuses on increasing the number of general customers, who pay for actual medical treatment, such as insurance companies, life insurance companies, and general customers. This includes setting appropriate marketing policies and strategies to achieve these goals, as well as building good relationships with insurance agents from various companies to build networks and trust in the Vichaiyut Hospital Group.
4. Increased demand for medical treatment. The long-term trend of the private hospital business can still grow continuously due to the increasing elderly population, the increase in per capita income, especially in the provinces, and the importance that people place on healthcare for a long and quality life. There are also positive factors from the demand for medical treatment from foreign patients who come to Thailand for health care (Medical Tourism) due to the value of medical treatment costs and the good quality of medical care.
5. The adoption of IFRS S1 (General Requirements for Disclosure of Sustainability-related Financial Information) and IFRS S2 (Climate-related Disclosures) for reporting and disclosing financial information, including sustainability and climate change risks, will increase transparency. These standards will be fully implemented in 2026.
The aforementioned factors will impact the company's future financial position and operations. To effectively and sustainably adapt to new standards and mitigate the impact of policy changes and external environmental factors, the company and its subsidiaries must adjust their strategies. This includes enhancing healthcare capabilities, expanding the general customer market with advanced medical technology, consistently offering new services, and strengthening the workforce. Furthermore, the company will focus on developing excellent service, expanding clinics to cover all diseases, and offering 24-hour service to accommodate future customer growth.

